The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMaven Grwth 3 Regulatory News (MIG3)

Share Price Information for Maven Grwth 3 (MIG3)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.00
Bid: 47.00
Ask: 49.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.255%)
Open: 48.00
High: 48.00
Low: 48.00
Prev. Close: 48.00
MIG3 Live PriceLast checked at -
Maven Income and Growth VCT 3 is an Investment Trust

To achieve long-term capital appreciation and generate income for Shareholders by investing in a diversified portfolio of securities in smaller, unquoted UK companies and AIM/NEX quoted companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allotment Update

8 Jun 2020 09:33

RNS Number : 2533P
Maven Income and Growth VCT 3 PLC
08 June 2020
 

Maven Income and Growth VCT 3 PLC (the Company)

 

Allotment Update

 

 

On 13 November 2019, the Company and Maven Income and Growth VCT 4 PLC launched a joint offer for subscription for new ordinary shares of 10p each (Ordinary Shares) to raise up to £7.5 million (the Offer). On 28 January 2020, the Board announced that it had received subscriptions up to its fundraising limit of £7.5 million and that the Offer was closed for further applications.

 

It was subsequently announced, on 5 February 2020, that the Board of the Company intended that an allotment in respect of applications for the 2020/2021 tax year would take place as soon as practicable after 6 April 2020. However, after undertaking a comprehensive review of the portfolio and making suitable provisions against the valuations of certain unlisted investments to reflect the impact that the COVID-19 pandemic could have on the trading performance of some of the underlying companies, on 26 March 2020 the Board announced an adjusted net asset value (NAV) of 55.91p per Ordinary Share as at 20 March 2020.

 

The Board had also announced on 26 March 2020 that it intended to delay the allotment for the 2020/2021 tax year to no earlier than 30 April 2020. This was in order to conduct a further review of the portfolio and ensure that the issue price would reflect the valuation of the underlying portfolio. This further review period has been extended in order to gain the fullest possible understanding of the impact of the pandemic over a longer period prior to allotment, but is expected to have been completed in time to allow the Company to announce an unaudited NAV in advance of the publication of the Interim Report and Financial Statements for the six months ended 31 May 2020. The Board anticipates that an unaudited NAV as at 31 May 2020 will be announced before 30 June 2020, with an allotment of shares in respect of the 2020/21 tax year taking place as soon as practicable thereafter.

 

For further information, please contact:

 

Maven Capital Partners UK LLP

Telephone: 0141 306 7400

E-mail: enquiries@mavencp.com

 

Maven Capital Partners UK LLP

Secretary

 

8 June 2020

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCVVLBBBQLXBBF
Date   Source Headline
8th Mar 20119:42 amRNSDirector/PDMR Shareholding
8th Mar 20119:32 amRNSDirector/PDMR Shareholding
2nd Mar 20119:54 amRNSTotal Voting Rights
1st Mar 20114:01 pmRNSAnnual Financial Report
2nd Feb 20114:12 pmRNSIssue of Equity
18th Nov 20102:43 pmRNSDirector/PDMR Shareholding
18th Nov 20102:00 pmRNSStatement re Linked Offer for Subscription
18th Nov 20101:18 pmRNSTransaction in Own Shares
3rd Nov 201011:10 amRNSDirector/PDMR Shareholding
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
20th Oct 20103:58 pmRNSStatement re Cancellation of Share Premium Account
14th Oct 20103:02 pmRNSInterim Management Statement
1st Sep 20103:22 pmRNSResult of EGM
6th Aug 20102:26 pmRNSCirc re. cancellation of share premium
9th Jul 20104:37 pmRNSHalf Yearly Report
28th May 20104:21 pmRNSTransaction in Own Shares
20th May 20109:05 amRNSTransaction in Own Shares
12th May 20109:16 amRNSInterim Management Statement
10th May 201011:21 amRNSTotal Voting Rights
7th May 201011:58 amRNSTransaction in Own Shares
7th May 20109:35 amRNSResult of AGM
4th May 20102:43 pmRNSIssue of Equity
30th Apr 201011:09 amRNSAnnual Information Update
6th Apr 201011:19 amRNSIssue of Equity
1st Apr 20105:24 pmRNSIssue of Equity
8th Mar 20105:53 pmRNSAnnual Financial Report
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
26th Jan 201011:15 amRNSLinked Offer for Subscription
5th Jan 201011:14 amRNSTotal Voting Rights
14th Dec 20099:59 amRNSChange of Name
7th Dec 200911:03 amRNSTransaction in Own Shares
26th Nov 200912:18 pmRNSResult of EGM
2nd Nov 20094:34 pmRNSChange of Adviser
30th Oct 20093:47 pmRNSNotice of EGM
16th Oct 200912:09 pmRNSInterim Management Statement
1st Sep 20099:39 amRNSTotal Voting Rights
3rd Aug 20093:53 pmRNSTransaction in Own Shares
27th Jul 20093:31 pmRNSCorrection to record date
24th Jul 20094:48 pmRNSHalf Yearly Report
10th Jun 200911:48 amRNSChange of Adviser
9th Apr 20093:55 pmRNSAGM Statement
9th Apr 20091:06 pmRNSInterim Management Statement
6th Apr 20092:57 pmRNSChange of Adviser
30th Mar 200911:05 amRNSAnnual Information Update
30th Mar 200910:15 amRNSAnnual Report and Accounts
10th Mar 200911:20 amRNSAnnual Report and Accounts
6th Mar 200910:26 amRNSC Ordinary shares (on conversion to Ordinary)
2nd Mar 200912:50 pmRNSConversion of Securities

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.